44 Mins
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
44 Minsالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
44 MinsReady to play
Ready to play
Experiments conducted by Mayo Clinic researchers showed significant improvement in some people with stiff-person syndrome after they were treated with T cells engineered to target the cells driving the disease. Some regained the ability to walk, work, and enjoy their hobbies. The results are preliminary, and researchers are still studying how long the improvements last, but they see the technique—previously used to treat some cancers—as a promising approach for neurological autoimmune diseases.
Notice: This Is an AI-Generated Summary
Comments (0)